Soma and Maxalt-mlt drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Soma (carisoprodol) and Maxalt-mlt (rizatriptan benzoate). Common drug interactions include hypokalaemia among females and disease progression among males.
The phase IV clinical study analyzes what interactions people have when they take Soma and Maxalt-mlt. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.
What is Soma?
Soma has active ingredients of carisoprodol. It is often used in muscle spasms. eHealthMe is studying from 17,137 Soma users. Check the latest studies of Soma.
What is Maxalt-mlt?
Maxalt-mlt has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 1,534 Maxalt-mlt users. Check the latest studies of Maxalt-mlt.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
23 people who take Soma and Maxalt-mlt together, and have interactions are studied.

What are the common drug interactions of Soma and Maxalt-Mlt, by gender? *:
female:
- Hypokalaemia (low potassium)
- Injury
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Panic attack
- Road traffic accident
- Scar
- Sinusitis (inflammation of sinus)
- Weight decreased
- Aggression
- Asthenia (weakness)
male:
- Disease progression
- Intervertebral disc disorder (spinal disc disorder)
What are the common drug interactions of Soma and Maxalt-Mlt, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Cholecystitis chronic (long lasting infection of gallbladder)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Injury
- Scar
30-39:
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Blood cholesterol increased
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Glaucoma (increased fluid pressure in the eye with vision loss)
- Hypertension (high blood pressure)
- Neuropathy peripheral (surface nerve damage)
- Purpura senile (skin condition in which areas of the skin develop a purplish or reddish-brown appearance due to bleeding of small blood vessels underneath)
- Renal failure (kidney dysfunction)
- Resorption bone increased
40-49:
- Anxiety
- Back disorder
- Depression
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Panic attack
- Road traffic accident
- Hypokalaemia (low potassium)
- Coronary artery thrombosis (clot formation in coronary artery)
50-59:
- Asthenia (weakness)
- Bradycardia (abnormally slow heart action)
- Chest pain
- Disease progression
- Homicidal ideation (thoughts about human killing another human)
- Homicide (human killing another human)
- Hypertriglyceridaemia (excess of triglycerides in the blood)
- Hypokalaemia (low potassium)
- Insomnia (sleeplessness)
- Intervertebral disc disorder (spinal disc disorder)
60+:
- Cavernous sinus thrombosis (formation of a blood clot in brain)
- Sinusitis (inflammation of sinus)
- Tooth abscess (pus formation in tooth)
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 30.43%
- Pain: 4 people, 17.39%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 17.39%
- Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 3 people, 13.04%
- Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 8.70%
- Premenstrual Syndrome: 2 people, 8.70%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 8.70%
- Birth Control: 2 people, 8.70%
* Approximation only. Some reports may have incomplete information.
Do you take Soma and Maxalt-mlt?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Soma (17,137 reports)
- Maxalt-mlt (1,534 reports)
Browse all drug interactions of Soma and Maxalt-mlt:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Soma:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Maxalt-mlt:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Soma and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Maxalt-mlt and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on carisoprodol and rizatriptan benzoate (the active ingredients of Soma and Maxalt-mlt, respectively), and Soma and Maxalt-mlt (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Methotrexate cause Small Intestine Carcinoma? - 7 seconds ago
- Could Prednisolone cause C-Reactive Protein Increased? - 8 seconds ago
- Drug interactions of Moviprep and Entyvio - 9 seconds ago
- Could Xarelto cause Arthritis Infective? - 11 seconds ago
- Drug interactions of Scopolamine and Lopressor - 19 seconds ago
- Drug interactions of B12 and Halobetasol Propionate - 19 seconds ago
- Could Magnesium Sulfate cause Pulmonary Oedema? - 25 seconds ago
- Drug interactions of Calcium and Albuterol Sulfate And Ipratropium Bromide - 25 seconds ago
- Could Clindamycin Hydrochloride cause Eye Irritation? - 31 seconds ago
- Metaproterenol Sulfate vs. Trandate, side effect and effectiveness comparison - 34 seconds ago